logo

For the Inventor, By the Inventor

Paris, France

Anne-Marie Moura

This inventor holds 9 USPTO granted patents. Top assignees: Roussel Uclaf, Hoechst Aktiengesellschaft. Active years: 1987-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne-Marie Moura. Retrieved from https://idiyas.com/inventor/anne-marie-moura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 52(Granted Patents)


Location History:

  • Moura, FR (1994)
  • Paris, FR (1987 - 1997)

Company Filing History:

goldMedal5 out of 854 
 
Roussel Uclaf
 patents
silverMedal4 out of 6,705 
 
Hoechst Aktiengesellschaft
 patents

Years Active: 1987-1997

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5661174 - Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their (1997-08-26),
2. 5498617 - Guanidinealkyl-1,1-bisphosphonic acid derivatives process for their (1996-03-12),
3. 5395826 - Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their (1995-03-07),
4. 5348971 - Indanes useful as analgesics (1994-09-20),
5. 5294608 - Guanidinoalkyl-1,1-bisphosphonic acid derivatives, process for their (1994-03-15),
6. 5130329 - Benzocyclohexanes and benzocycloheptanes useful as analgesics (1992-07-14),
7. 5068244 - Benzocyclohexanes and analgesic compositions thereof (1991-11-26),
8. 4987128 - Novel 10.beta.-alkynyl-steroids (1991-01-22),
9. 4701449 - Novel 10-substituted steroids and their use in the induction of (1987-10-20),

Title: Anne-Marie Moura: Pioneering Innovator in Pharmaceutical Patents

Introduction: Anne-Marie Moura, a distinguished inventor based in Paris, FR, has made significant contributions to the world of pharmaceutical patents. With a total of 9 patents to his name, Moura's innovative spirit and dedication to excellence have established him as a leading figure in the field.

Latest Patents: Among his latest patents is the development of Guanidinealkyl-1,1-bisphosphonic acid derivatives. These compounds, outlined in the tautomeric formula Ia, Ib, or Ic, have shown efficacy in the treatment and prevention of degenerative bone disorders. With applications in pharmaceuticals, Moura's work demonstrates a commitment to advancing medical solutions.

Career Highlights: Anne-Marie Moura has an extensive professional background, having worked with renowned companies such as Roussel Uclaf and Hoechst Aktiengesellschaft. His tenure at these organizations has allowed him to explore new avenues for innovation and further refine his expertise in pharmaceutical patents.

Collaborations: Throughout his career, Moura has collaborated with esteemed colleagues such as Christoph Naumann and Hans-Jochen Lang. These partnerships have fueled his creative process and provided insights that have shaped his groundbreaking inventions in the pharmaceutical domain.

Conclusion: In conclusion, Anne-Marie Moura's unwavering passion for innovation and his remarkable contributions to the field of pharmaceutical patents have left an indelible mark on the industry. His work serves as an inspiration to aspiring inventors, urging them to push boundaries and strive for a brighter future through groundbreaking inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…